Korean biotech firm takes second shot at Singapore backdoor listing
Add BT as a preferred sourceSingapore
A SOUTH KOREAN steelmaker controls a firm that makes kimchi lactobacillus (lactic acid bacteria) is trying again to secure a listing for the latter biotech firm by a backdoor route.
Stainless steel manufacturer Kossen, a key shareholder of BiogenicsKorea, has signed an implementation agreement with Epicentre Holdings (the former authorised Apple retailer) and Tardis Capital, said Epicentre's judicial managers (JMs) on Wednesday.
TRENDING NOW
Japan Home closing outlets; staff say Valu$ taking over operations
How BYD disrupted Singapore’s car market – and why the strategy is turning on itself
From sales executive to DBS chairman: A look at banking veteran Peter Seah’s career
Timah Partners lands S$60 million facility from lenders including UOB, RHB
